New Anticoagulant Pill Works Well in Trial
... 17 (HealthDay News) -- The new anti-clotting pill rivaroxaban
(Xarelto) lowers the risk of stroke, heart attack ...suffer from unstable angina, a new trial shows.
is a pill that blocks factor Xa, which is involved... these observations, a phase III study of low-dose rivaroxaban
as adjunctive therapy in these patients is underwa...
FDA Panel Backs New Anti-Clotting Drug
could replace heparin after hip- or knee-replaceme...e benefits of the experimental blood-thinning drug rivaroxaban
outweigh its risks, a U.S. Food and Drug Administration advisory panel said Thursday.
(Xarelto) could be one of the long-sought alternat...
Research highlights new approaches to prevent blood clots
...rates of secondary endpoints.
Once-Daily Oral rivaroxaban
Compared With Subcutaneous Enoxaparin Every 12 Hou...ous research that demonstrated that post-operative rivaroxaban
was more effective than pre-operative enoxaparin i... were randomized to receive either once-daily oral rivaroxaban
(10 mg) starting six to eight hours after surgery ...
Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data
a study of a new oral anti-clotting agent -- rivaroxaban
-- designed to
identify doses that would be safe t...
Earlier studies had shown the experimental drug rivaroxaban
at keeping blood clots from forming in t...ndomized to
twice a day doses of 2.5 mg or 5 mg of rivaroxaban
for six months is
expected to begin in December 20...
Speed Not Always of the Essence With Heart Cases in ER
The study was the first to look at the effects of the drug in the arteries.
Existing drugs target the platelets in the bloodstream. rivaroxaban
targets a different part of the clotting process, called Factor X, said principal investigator Dr. Michael Gibson, chief of clinical research in cardi...
Oral Drug Helps Prevent Clotting After Hip Replacement
... Daily dose of rivaroxaban
cut risk of venous thromboembolism, study finds
... (HealthDay News) -- Extended use of the oral drug rivaroxaban
helps prevent potentially fatal blood clots after ...nstitute compared the new oral antithrombotic drug rivaroxaban
(Xarelto) with enoxaparin in the treatment of hip ...
Rivaroxaban phase III pivotal data presented at EFORT annual meeting
...ent (TKR) surgery. The head-to-head study compared rivaroxaban
with the U.S.-approved dosing regimen for enoxapar...ociations of Orthopaedics & Traumatology (EFORT). rivaroxaban
is being jointly developed by Johnson & Johnson Ph...ayer HealthCare AG.
The RECORD4 data show that rivaroxaban
(10mg once-daily) provided TKR surgery patients a ...
Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders
...red dose of an oral, direct Factor Xa inhibitor
-- for extended prevention of blood clotting after... III
trial studied the efficacy and safety of oral rivaroxaban
in comparison to
subcutaneous enoxaparin to preven...l of 4,541 randomized patients who either received rivaroxaban
beginning six to eight hours after surgery a...